查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417534

神经诊断市场报告：2030 年趋势、预测与竞争分析

Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

神经诊断的趋势和预测

到 2030 年，全球神经诊断市场预计将达到 127 亿美元，2024 年至 2030 年复合年增长率为 7.1%。这个市场的主要驱动因素是神经系统疾病和神经病变的盛行率不断增加、患者对准确及时的疾病诊断的兴趣不断提高，以及神经退化性疾病诊断的基因组学和蛋白​​质组学的进步。全球神经诊断市场的未来看起来充满希望，医院和外科中心、神经科中心、门诊医疗中心、诊断实验室和影像中心、实验室和学术实验室市场都有机会。

神经诊断市场洞察

Lucintel 预测，由于脑部外伤、失智症、巴金森氏症和亨廷顿舞蹈症的盛行率不断上升，神经退化性疾病在预测期内仍将是最大的部分。

由于其发达的医疗保健系统、医疗相关人员对现代神经诊断设备的广泛接受以及易于获得先进的神经诊断技术，北美在预测期内将继续成为最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球神经诊断市场预计将达到 127 亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球神经诊断市场预计将以7.1%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是神经系统疾病和神经病变的盛行率不断增加、患者对准确及时的疾病诊断的兴趣日益浓厚，以及神经退化性疾病诊断的基因组学和蛋白​​质组学的进步。

Q4.市场的主要细分市场是什么？

A4. 全球神经诊断市场的未来充满希望，医院/外科中心、神经内科中心、门诊医疗中心、诊断实验室/影像中心、实验室/学术实验室市场都有机会。

Q5. 市场上主要企业有哪些？

A5. 神经诊断领域的主要企业如下。

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于脑外伤、失智症、巴金森氏症和亨廷顿舞蹈症的盛行率不断上升，神经退化性疾病在预测期内仍将是其最大的部分。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于其发达的医疗保健系统、医疗相关人员对现代神经诊断设备的广泛接受以及易于获得先进的神经诊断技术，北美在预测期内将继续成为最大的地区。继续。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球神经诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球神经诊断市场趋势（2018-2023）与预测（2024-2030）
  • 全球神经诊断市场（按产品）
    • 介绍
    • 诊断和影像系统
    • 临床检测设备
    • 试剂及耗材
  • 按状况分類的全球神经诊断市场
    • 神经退化性疾病
    • 癫痫
    • 中风
    • 头痛症
    • 睡眠失调
    • 其他的
  • 按最终用途分類的全球神经诊断市场
    • 医院及手术中心
    • 神经中枢
    • 门诊治疗中心
    • 诊断实验室和影像中心
    • 研究和学术机构
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球神经诊断市场区域分布
  • 北美神经诊断市场
  • 欧洲神经诊断市场
  • 亚太神经诊断市场
  • 其他地区神经诊断市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品分類的全球神经诊断市场成长机会
    • 按条件分類的全球神经诊断市场成长机会
    • 按最终用途分類的全球神经诊断市场成长机会
    • 按地区分類的全球神经诊断市场成长机会
  • 全球神经诊断市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球神经诊断市场的产能
    • 全球神经诊断市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar
简介目录

Neurodiagnostics Trends and Forecast

The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets. The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

A more than 150-page report is developed to help in your business decisions.

Neurodiagnostics by Segment

The study includes a forecast for the global neurodiagnostics by product, condition, end use, and region.

Neurodiagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Introduction
  • Diagnostic And Imaging Systems
  • Clinical Testing Instruments
  • Reagents & Consumables

Neurodiagnostics Market by Condition [Shipment Analysis by Value from 2018 to 2030]:

  • Neuro Degenerative Diseases
  • Epilepsy
  • Stroke
  • Headache Disorders
  • Sleep Disorders
  • Others

Neurodiagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals And Surgery Centers
  • Neurology Centers
  • Ambulatory Care Centers
  • Diagnostic Laboratories & Imaging Centers
  • Research Laboratories & Academic Institutes
  • Others

Neurodiagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Neurodiagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurodiagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurodiagnostics companies profiled in this report include-

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar

Neurodiagnostics Market Insights

Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Features of the Global Neurodiagnostics Market

Market Size Estimates: Neurodiagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurodiagnostics market size by product, condition, end use, and region in terms of value ($B).

Regional Analysis: Neurodiagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, condition, end use, and regions for the neurodiagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurodiagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the neurodiagnostics market size?

Answer: The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030.

Q2. What is the growth forecast for neurodiagnostics market?

Answer: The global neurodiagnostics market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the neurodiagnostics market?

Answer: The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

Q4. What are the major segments for neurodiagnostics market?

Answer: The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets.

Q5. Who are the key neurodiagnostics market companies?

Answer: Some of the key neurodiagnostics companies are as follows.

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar

Q6. Which neurodiagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

Q7. In neurodiagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the neurodiagnostics market by product (introduction, diagnostic and imaging systems, clinical testing instruments, and reagents & consumables), condition (neuro degenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and others), end use (hospitals and surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, research laboratories & academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neurodiagnostics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Neurodiagnostics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Neurodiagnostics Market by Product
    • 3.3.1: Introduction
    • 3.3.2: Diagnostic and Imaging Systems
    • 3.3.3: Clinical Testing Instruments
    • 3.3.4: Reagents & Consumables
  • 3.4: Global Neurodiagnostics Market by Condition
    • 3.4.1: Neuro Degenerative Diseases
    • 3.4.2: Epilepsy
    • 3.4.3: Stroke
    • 3.4.4: Headache Disorders
    • 3.4.5: Sleep Disorders
    • 3.4.6: Others
  • 3.5: Global Neurodiagnostics Market by End Use
    • 3.5.1: Hospitals and Surgery Centers
    • 3.5.2: Neurology Centers
    • 3.5.3: Ambulatory Care Centers
    • 3.5.4: Diagnostic Laboratories & Imaging Centers
    • 3.5.5: Research Laboratories & Academic Institutes
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Neurodiagnostics Market by Region
  • 4.2: North American Neurodiagnostics Market
    • 4.2.1: North American Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.2.2: North American Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
  • 4.3: European Neurodiagnostics Market
    • 4.3.1: European Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.3.2: European Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
  • 4.4: APAC Neurodiagnostics Market
    • 4.4.1: APAC Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.4.2: APAC Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
  • 4.5: ROW Neurodiagnostics Market
    • 4.5.1: ROW Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.5.2: ROW Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Neurodiagnostics Market by Product
    • 6.1.2: Growth Opportunities for the Global Neurodiagnostics Market by Condition
    • 6.1.3: Growth Opportunities for the Global Neurodiagnostics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Neurodiagnostics Market by Region
  • 6.2: Emerging Trends in the Global Neurodiagnostics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Neurodiagnostics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurodiagnostics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Siemens Healthineers
  • 7.3: Philips Healthcare
  • 7.4: Canon
  • 7.5: Hitachi
  • 7.6: Lifelines Neuro Company
  • 7.7: Natus Medical
  • 7.8: Hoffman-La Roche
  • 7.9: FUJIFILM Holdings
  • 7.10: Mitsar